Silvant Capital Management’s Aimmune Therapeutics, Inc. AIMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-10,288
Closed -$172K 341
2020
Q2
$172K Buy
10,288
+2,669
+35% +$44.6K 0.03% 181
2020
Q1
$110K Hold
7,619
0.02% 192
2019
Q4
$255K Buy
+7,619
New +$255K 0.05% 166